Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Document › Details

BIA Separations d.o.o.. (10/10/17). "Press Release: BIA Separations and Nuvonis Technologies Announce the signing of an Agreement to Collaborate on the Sales and Marketing of Their Technologies and Process Development Know-how". Ajdovšcina & Vienna.

Organisations Organisation BIA Separations d.o.o.
  Group Sartorius (Group)
  Organisation 2 Nuvonis Technologies GmbH
Product Product  chromatography
Index term Index term BIA Separations–Nuvonis: vaccine + gene therapy production technology, 201710– collab co-marketing of cell lines + purification technologies

BIA Separations and Nuvonis Technologies announce the signing of an agreement to collaborate on the sales and marketing of their technologies and process development know-how in order to target the business requirements of large, medium and small size vaccine and gene therapy enterprise customers and meet growing market demand. Business development teams from both companies will collaborate to present the advantages of the initiative's offerings to joint customers. Choosing a well characterized Vero cell substrate and designing a simple high yield purification process is an important strategic element to most vaccine and gene therapy companies.

About Nuvonis:

Nuvonis is biotech company based in Vienna, Austria, providing innovative cell banks and technical support for vaccine process development. The Nuvonis team is highly experienced in cell line and process optimization for vaccine production.

The proprietary and fully characterized Nuvonis Vero cells are cultivated without animal derived media or protease additives and are non-tumorigenic beyond the end of production passage. This cell bank can be licensed for viral vaccine and vector manufacturing.

Nuvonis has developed simple and highly efficient virus purification procedure based on a combined precipitation step. This purification method leads to increased virus yield (up to 90%) and low host cell protein and DNA impurity levels.

More informations about Nuvonis.

Record changed: 2023-06-05


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Sartorius (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px

» top